The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...